Balanced news tone
News Sentiment
MRK sentiment intelligence
Merck & Co., Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
57
Balanced news tone
26 relevant articles
News tone and price action are not far from neutral.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-3.1% over one week, +9.6% over four weeks, trend active, and materially above fair value.
The Real Question Buried Inside Merck Stock’s Premium Price
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
83/100 classification
One-week reaction
-3.1%
Price reacting lower
Trend fit
Trend active
9.6% over four weeks
Fair value
48.2%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
7
Neutral
19
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Trefis
Direct company coverage
The Real Question Buried Inside Merck Stock’s Premium Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 22:01
- Source
- Trefis
Investor's Business Daily
Direct company coverage
Merck Reportedly Goes To Bat In Takeover Battle. But Genomics Stock Reverses.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 20:12
- Source
- Investor's Business Daily
Seeking Alpha
Direct company coverage
Merck: 'Strong Buy' Lipfendra FDA First And Continued Oncology Expansions (NYSE:MRK)
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 17 Jul 2026 19:30
- Source
- Seeking Alpha
Market source
Direct company coverage
New Cholesterol Pill, Earnings Growth Boost Merck Shares
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 17 Jul 2026 12:40
- Source
- Market source
Investing.com
Direct company coverage
Guggenheim reiterates Merck stock rating on Lipfendra approval
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 17 Jul 2026 12:08
- Source
- Investing.com
Investor's Business Daily
Direct company coverage
Merck Snags A First-Ever Approval; Shares Pop
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 16 Jul 2026 20:07
- Source
- Investor's Business Daily
Market source
Direct company coverage
Merck (MRK) Stock Sees Modest Fair Value Lift As Analysts Raise Targets
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 16:12
- Source
- Market source
Quiver Quantitative
Direct company coverage
Why Merck & Co. (MRK) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 15:36
- Source
- Quiver Quantitative
Investor's Business Daily
Direct company coverage
Dow Jones' Merck Scores A Win With Cancer Smart Bomb
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 20:17
- Source
- Investor's Business Daily
Market source
Direct company coverage
Merck (MRK) Stock Looks Like A Bargain At This Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 13:09
- Source
- Market source
Market source
Direct company coverage
Merck (MRK) Stock Sinks As Market Gains: Here's Why
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jul 2026 21:45
- Source
- Market source
Investor's Business Daily
Direct company coverage
Merck Stock, JPMorgan And Two Others Hit New Highs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Investor's Business Daily
Market source
Direct company coverage
MRK, NEUP Stocks Drop As Merck Scraps Another Alzheimer’s Drug Trial Under Neuphoria Partnership
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 01 Jul 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Merck (MRK) Stock Weighs Strong Rally Against Mixed Valuation Signals
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 26 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Merck (MRK) Stock Gets New Outperform Rating from CICC
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 24 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Merck (MRK) Stock After 53% One-Year Gain Is DCF Signaling Further Upside Potential
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- Market source
ICIJ
Direct company coverage
How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide - International Consortium of Investigative Journalists
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Apr 2026 07:00
- Source
- ICIJ
CHEManager
Direct company coverage
Merck & Co. Deepens Hematology Pipeline with $6.7 Billion Terns Acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Apr 2026 07:00
- Source
- CHEManager
AskTraders
Direct company coverage
Merck Stock (MRK) Hitting Highs Into Earnings – Eyes On Breakout
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Feb 2026 08:00
- Source
- AskTraders
Fortune
Direct company coverage
Merck touts 20 new ‘blockbuster’ drugs in development with $50 billion potential
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2025 08:00
- Source
- Fortune
Pharmaceutical Technology
Direct company coverage
Merck & Co bolsters neurogenerative portfolio with Caraway acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 21 Nov 2023 08:00
- Source
- Pharmaceutical Technology
Pharmaceutical Technology
Direct company coverage
Merck agrees to acquire Acceleron Pharma for $11.5bn
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Oct 2021 07:00
- Source
- Pharmaceutical Technology
GuruFocus
Direct company coverage
Merck & Co Inc (MRK) Stock Price, Trades & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Apr 2019 05:43
- Source
- GuruFocus
CBS News
Direct company coverage
Merck, Schering-Plough Plan $41.1B Merger
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Mar 2009 07:00
- Source
- CBS News
Merck.com
Direct company coverage
Merck | Home
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Mar 2006 20:20
- Source
- Merck.com